Pharma

Taking stock of the drug industry, from the lab to the medicine chest

Pill graph
Pharma

Here are the biopharma companies that launched the most drugs over the past decade

By Matthew Herper

Pfizer R&D illo
Business

Pfizer’s chessmaster: How a top scientist helped invigorate a lumbering drug giant

By Matthew Herper

Chest X-ray pneumonia
Pharmalot

Doctors Without Borders criticizes the Gavi coalition over access to pneumonia vaccines

By Ed Silverman

Negative positive
Pharmalot

Pharma’s image among Americans has ‘fallen to a new low’

By Ed Silverman

Pharmalot

Pharmalittle: Some states object to Purdue opioid deal; top pharma CEOs donate to key Republicans

By Ed Silverman

3D molecule
Health Tech

AI system can create novel drug candidates in just 46 days, study finds

By Casey Ross

Hires
Pharmalot

Up and down the ladder: the latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Hormone therapy link to breast cancer strengthened; where did Sacklers’ Purdue money end up?

By Elizabeth Cooney

FDA
Pharmalot

Academics and consumer groups protest FDA plan to summarize review documents

By Ed Silverman

Pharmalot

Pharmalittle: National Academies opioid panel had conflicts; Amgen loses round in patent wars

By Ed Silverman

DEA Prescription Drug
Pharmalot

Medicare Part D paid millions for drugs already covered by Part A hospice benefits

By Ed Silverman

Drug pricing euros
Pharmalot

Dutch health minister threatens to name and shame pharma over prices

By Ed Silverman

Pharmalot

Pharmalittle: Purdue may settle opioid cases for $12 billion; Florida importation plan has lots of holes

By Ed Silverman

Opioid Crisis Lawsuits
Pharmalot

The J&J opioid case in Oklahoma darkens the outlook for other drug companies

By Ed Silverman

Pharmalot

Pharmalittle: J&J ordered to pay $572m in Oklahoma opioid case; Canada reassures pharma on importation

By Ed Silverman

Play
Pharma

Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing

By David Armstrong — ProPublica

Novartis International pharmaceutical
Pharmalot

An FDA report reveals the agency believed Novartis data problems were resolved months ago

By Ed Silverman

MS medication
Pharmalot

Price hikes for multiple sclerosis drugs helped Medicare Part D out-of-pocket costs to skyrocket

By Ed Silverman

purdue collage
Pharma

STAT wins long legal fight as Kentucky Supreme Court clears way for release of Purdue OxyContin files

By Andrew Joseph and Casey Ross

Pharmalot

Pharmalittle: Merck calls new Canadian pricing rules unconstitutional; J&J ruling today

By Ed Silverman

Failure to report clinical trial data can affect future research strategies and patient safety.
Pharmalot

U.K. lawmaker renews push to sanction companies and universities for clinical trial transparency failures

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Are Trump supporters less concerned with drug prices? An Amgen-Alexion report draws skepticism

By Ed Silverman

Purdue Pharmaceuticals
Pharmalot

Report: The Sacklers controlled Purdue like the Godfather controlled the Mafia

By Ed Silverman

Pharmalot

Pharmalittle: Trump pushes VA to buy controversial J&J drug; Gilead challenges U.S. patents on HIV pill

By Ed Silverman

Gilead
Pharmalot

Gilead challenges U.S. government patents on a controversial HIV prevention pill

By Ed Silverman

Insulin NOVO NORDISK
Pharmalot

The cost of diabetes drugs is causing more Americans to skip their meds

By Ed Silverman

Pharmalot

Pharmalittle: AstraZeneca stumbles in lung cancer; FDA official on Novartis data scandal says ‘we got lucky’

By Ed Silverman

Pharmalot
Pharmalot

Drug maker pays $200,000 to settle charges of unfairly disclosing material info to analysts

By Ed Silverman

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy